Home > Healthcare > Medical Devices > Therapeutic Devices > Intravenous Infusion Pump Market
Intravenous Infusion Pump Market Share
- Report ID: GMI5528
- Published Date: Mar 2023
- Report Format: PDF
Intravenous Infusion Pump Market Share
The competitive landscape of the intravenous infusion pump market comprises companies such as :
- F. Hoffmann-La Roche Ltd.
- Boston Scientific Corporation
- Fresenius Kabi
- Moog Inc.
- Terumo Corporation
- Tandem Diabetes Care, Inc.
- Micrel Medical Devices SA
- Shenzhen ENMIND Technology Co., Ltd.
- Medtronic
- ICU Medical
- IRadimed Corporation
- Becton
- Dickinson and Company, B.
- Braun Melsungen AG
- and Baxter International Inc.
Product portfolio expansions and collaborations are some of the key initiatives being undertaken by these companies to reinforce their market presence.
Frequently Asked Questions (FAQ) :
Global market for intravenous infusion pump exceeded USD 5.5 billion in 2022 and will depict over 5% CAGR through 2023-2032, as a result of the growing prevalence of cancer and other chronic diseases.
Syringe product segment is slated to reach over USD 3 billion by 2032, owing to the product’s application scope as an excellent medicine delivery method for palliative care.
North America region held a 36% share of the intravenous infusion pump industry over 2023-2032, due to the high prevalence of bleeding disorders including hemophilia.
Key players in the intravenous infusion pump market include F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Medtronic, ICU Medical, Becton, Dickinson and Company, B. Braun Melsungen AG, and Baxter International Inc., among others.
Intravenous Infusion Pump Market Scope
×
Get a free sample of
Intravenous Infusion Pump Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below